Shareholding disclosure

Addex Therapeutics Ltd

Collectively declared rate

16.33%

Threshold

Crossed upwards

Timeline

Published

16.01.2021

Transaction

12.01.2021

Voting rights breakdown

Voting rights acquired16.33%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBL1E00016

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

Addex Therapeutics Ltd, 1228 Plan-Les-Ouates

Crossing down below 15% threshold of the shares hold by Addex Therapeutics Ltd (14.59%)following the capital increase published on the SHAB on January 12, 2021 Addex Therapeutics Ltd : the lock-up agreement terminates on March 8,2021 Board and executive members: the lock-up agreement terminates on April 7, 2021

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open